Xu, H., Zeng, L., Guan, Y., Feng, X., Zhu, Y., Lu, Y., . . . Zhou, W. (2018). High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma. J Cell Biochem.
Citação norma ChicagoXu, He, et al. "High NEK2 Confers to Poor Prognosis and Contributes to Cisplatin‐based Chemotherapy Resistance in Nasopharyngeal Carcinoma." J Cell Biochem 2018.
Citação norma MLAXu, He, et al. "High NEK2 Confers to Poor Prognosis and Contributes to Cisplatin‐based Chemotherapy Resistance in Nasopharyngeal Carcinoma." J Cell Biochem 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.